My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Actas Urológicas Españolas
Print version ISSN 0210-4806
Abstract
GARCIA GONZALEZ, Jorge et al. Use of M-VAC in the adjuvant treatment of sarcomatoid carcinoma of the bladder. Actas Urol Esp [online]. 2009, vol.33, n.4, pp.447-449. ISSN 0210-4806.
Sarcomatoid bladder carcinoma is a high-grade neoplasm and accounts for approximately 0,3% of all bladder malignancies. Sarcomatoid carcinoma originates from transitional cells of the bladder. Sarcomatoid carcinoma is charactericed by a epithelial component and a sarcomatoid component, consisting of spindle cells, that is only epithelial marker-positive. We report a 26 year-old woman diagnosed of stage III sarcomatoid bladder carcinoma (T3aN0M0) treated with partial cistectomy followed by 4 cycles of adjuvant chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.
Keywords : Bladder carcinoma; Sarcomatoid carcinoma; Immunohistochemestry; Cytokeratins; Chemotherapy.